Corrigendum to: TW-01, a piperazinedione-derived compound, inhibits Ras-mediated cell proliferation and angioplasty-induced vascular restenosis “Toxicol Appl Pharmacol. 2016;305:194–202” (Toxicology and Applied Pharmacology (2016) 305 (194–202)(S0041008X16301478)(10.1016/j.taap.2016.06.013))

Chao Feng Lin; Han Li Huang; Chieh Yu Peng; Yu Ching Lee; Hui Po Wang; Che Ming Teng; Shiow Lin Pan

doi:10.1016/j.taap.2019.114858

Corrigendum to: TW-01, a piperazinedione-derived compound, inhibits Ras-mediated cell proliferation and angioplasty-induced vascular restenosis “Toxicol Appl Pharmacol. 2016;305:194–202” (Toxicology and Applied Pharmacology (2016) 305 (194–202)(S0041008X16301478)(10.1016/j.taap.2016.06.013))

Chao Feng Lin
, Han Li Huang
, Chieh Yu Peng
, Yu Ching Lee
, Hui Po Wang
, Che Ming Teng
, Shiow Lin Pan

研究成果: 雜誌貢獻 › 評論/辯論 › 同行評審

摘要

The authors regret that an incorrect description of the author's affiliation “a” has to be revised. The correct description of affiliation “a” is: Ph.D. Program for Cancer Molecular Biology and Drug Discovery, College of Medical Science and Technology, Taipei Medical University and Academia Sinica. The authors would like to apologise for any inconvenience caused.

原文	英語
文章編號	114858
期刊	Toxicology and Applied Pharmacology
卷	387
DOIs	https://doi.org/10.1016/j.taap.2019.114858
出版狀態	已發佈 - 1月 15 2020

UN SDG

此研究成果有助於以下永續發展目標

SDG 3 良好的健康和福祉

ASJC Scopus subject areas

毒理學
藥理

存取文件

10.1016/j.taap.2019.114858

其它文件與鏈接

指紋

深入研究「Corrigendum to: TW-01, a piperazinedione-derived compound, inhibits Ras-mediated cell proliferation and angioplasty-induced vascular restenosis “Toxicol Appl Pharmacol. 2016;305:194–202” (Toxicology and Applied Pharmacology (2016) 305 (194–202)(S0041008X16301478)(10.1016/j.taap.2016.06.013))」主題。共同形成了獨特的指紋。

引用此

Lin, C. F., Huang, H. L., Peng, C. Y., Lee, Y. C., Wang, H. P., Teng, C. M., & Pan, S. L. (2020). Corrigendum to: TW-01, a piperazinedione-derived compound, inhibits Ras-mediated cell proliferation and angioplasty-induced vascular restenosis “Toxicol Appl Pharmacol. 2016;305:194–202” (Toxicology and Applied Pharmacology (2016) 305 (194–202)(S0041008X16301478)(10.1016/j.taap.2016.06.013)). Toxicology and Applied Pharmacology, 387, 文章 114858. https://doi.org/10.1016/j.taap.2019.114858

Corrigendum to: TW-01, a piperazinedione-derived compound, inhibits Ras-mediated cell proliferation and angioplasty-induced vascular restenosis “Toxicol Appl Pharmacol. 2016;305:194–202” (Toxicology and Applied Pharmacology (2016) 305 (194–202)(S0041008X16301478)(10.1016/j.taap.2016.06.013)). / Lin, Chao Feng; Huang, Han Li; Peng, Chieh Yu 等.
於: Toxicology and Applied Pharmacology, 卷 387, 114858, 15.01.2020.

研究成果: 雜誌貢獻 › 評論/辯論 › 同行評審

Lin, CF, Huang, HL, Peng, CY, Lee, YC, Wang, HP, Teng, CM & Pan, SL 2020, 'Corrigendum to: TW-01, a piperazinedione-derived compound, inhibits Ras-mediated cell proliferation and angioplasty-induced vascular restenosis “Toxicol Appl Pharmacol. 2016;305:194–202” (Toxicology and Applied Pharmacology (2016) 305 (194–202)(S0041008X16301478)(10.1016/j.taap.2016.06.013))', Toxicology and Applied Pharmacology, 卷 387, 114858. https://doi.org/10.1016/j.taap.2019.114858

Lin CF, Huang HL, Peng CY, Lee YC, Wang HP, Teng CM 等. Corrigendum to: TW-01, a piperazinedione-derived compound, inhibits Ras-mediated cell proliferation and angioplasty-induced vascular restenosis “Toxicol Appl Pharmacol. 2016;305:194–202” (Toxicology and Applied Pharmacology (2016) 305 (194–202)(S0041008X16301478)(10.1016/j.taap.2016.06.013)). Toxicology and Applied Pharmacology. 2020 1月 15;387:114858. doi: 10.1016/j.taap.2019.114858

Lin, Chao Feng ; Huang, Han Li ; Peng, Chieh Yu 等. / Corrigendum to : TW-01, a piperazinedione-derived compound, inhibits Ras-mediated cell proliferation and angioplasty-induced vascular restenosis “Toxicol Appl Pharmacol. 2016;305:194–202” (Toxicology and Applied Pharmacology (2016) 305 (194–202)(S0041008X16301478)(10.1016/j.taap.2016.06.013)). 於: Toxicology and Applied Pharmacology. 2020 ; 卷 387.

@article{08e66a17666f410e9cbe365154fcc276,

title = "Corrigendum to: TW-01, a piperazinedione-derived compound, inhibits Ras-mediated cell proliferation and angioplasty-induced vascular restenosis “Toxicol Appl Pharmacol. 2016;305:194–202” (Toxicology and Applied Pharmacology (2016) 305 (194–202)(S0041008X16301478)(10.1016/j.taap.2016.06.013))",

abstract = "The authors regret that an incorrect description of the author's affiliation “a” has to be revised. The correct description of affiliation “a” is: Ph.D. Program for Cancer Molecular Biology and Drug Discovery, College of Medical Science and Technology, Taipei Medical University and Academia Sinica. The authors would like to apologise for any inconvenience caused.",

author = "Lin, \{Chao Feng\} and Huang, \{Han Li\} and Peng, \{Chieh Yu\} and Lee, \{Yu Ching\} and Wang, \{Hui Po\} and Teng, \{Che Ming\} and Pan, \{Shiow Lin\}",

note = "Publisher Copyright: {\textcopyright} 2016 Elsevier Inc.",

year = "2020",

month = jan,

day = "15",

doi = "10.1016/j.taap.2019.114858",

language = "English",

volume = "387",

journal = "Toxicology and Applied Pharmacology",

issn = "0041-008X",

publisher = "Academic Press Inc.",

}

TY - JOUR

T1 - Corrigendum to

T2 - TW-01, a piperazinedione-derived compound, inhibits Ras-mediated cell proliferation and angioplasty-induced vascular restenosis “Toxicol Appl Pharmacol. 2016;305:194–202” (Toxicology and Applied Pharmacology (2016) 305 (194–202)(S0041008X16301478)(10.1016/j.taap.2016.06.013))

AU - Lin, Chao Feng

AU - Huang, Han Li

AU - Peng, Chieh Yu

AU - Lee, Yu Ching

AU - Wang, Hui Po

AU - Teng, Che Ming

AU - Pan, Shiow Lin

PY - 2020/1/15

Y1 - 2020/1/15

N2 - The authors regret that an incorrect description of the author's affiliation “a” has to be revised. The correct description of affiliation “a” is: Ph.D. Program for Cancer Molecular Biology and Drug Discovery, College of Medical Science and Technology, Taipei Medical University and Academia Sinica. The authors would like to apologise for any inconvenience caused.

AB - The authors regret that an incorrect description of the author's affiliation “a” has to be revised. The correct description of affiliation “a” is: Ph.D. Program for Cancer Molecular Biology and Drug Discovery, College of Medical Science and Technology, Taipei Medical University and Academia Sinica. The authors would like to apologise for any inconvenience caused.

UR - https://www.scopus.com/pages/publications/85077731147

UR - https://www.scopus.com/pages/publications/85077731147#tab=citedBy

U2 - 10.1016/j.taap.2019.114858

DO - 10.1016/j.taap.2019.114858

M3 - Comment/debate

C2 - 31843362

AN - SCOPUS:85077731147

SN - 0041-008X

VL - 387

JO - Toxicology and Applied Pharmacology

JF - Toxicology and Applied Pharmacology

M1 - 114858

ER -